On August 26, bgi genomics stated at the performance briefing that in the future, the company will pay close attention to the development of overseas fertility health business, especially the market layout in high fertility rate areas such as Southeast Asia, West Asia, and Latin America. The company will continue to increase its investment in these areas in order to further expand the international market for fertility health business.
华大基因：加大东南亚、西亚和拉美等高生育率地区的市场布局
bgi genomics: to expand the market layout in high fertility rate areas such as Southeast Asia, West Asia, and Latin America.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated